{"id":274039,"date":"2026-09-28T11:39:16","date_gmt":"2026-09-28T06:09:16","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=274039"},"modified":"2026-09-28T11:39:18","modified_gmt":"2026-09-28T06:09:18","slug":"themis-medicare-share-bull-case-vs-bear-case-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/themis-medicare-share-bull-case-vs-bear-case-2026\/","title":{"rendered":"Themis Medicare Share: Bull Case vs Bear Case for 2026"},"content":{"rendered":"
<\/div>\n
\n

Quick Answer<\/strong><\/p>\n

The Themis Medicare bull case for 2026 points toward the stock retesting its 52 week high of Rs 148.00, built on the strengths discussed below. The Themis Medicare bear case points toward a slide back near its 52 week low of Rs 64.95 if the risks play out instead. The stock currently trades at Rs 121.37, with a price to earnings multiple of 26.98 (Industry PE 38.42). The next two quarters of earnings and sector data will likely decide which case plays out.<\/p>\n<\/div>\n

The Themis Medicare bull case is under the spotlight as investors weigh Themis Medicare’s recent price action against its underlying fundamentals. The stock trades at Rs 121.37, against a 52 week high of Rs 148.00 and a 52 week low of Rs 64.95, leaving room for both the Themis Medicare bull case and the Themis Medicare bear case to find support in the data.<\/p>\n

Themis Medicare operates in the Pharmaceuticals space, and its return on equity of 0.42 percent and debt to equity ratio of 0.25 form part of the fundamental picture. This article lays out the full Themis Medicare bull case and bear case, the data behind each scenario, and the catalysts that could tip the balance one way or the other.<\/p>\n

Click Here \u2013 Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n